Heat Biologics to price initial public stock offering on July 23

Company plans to price stock at $10.00 to $12.00 per share

By Aleesia Forni

Virginia Beach, Va., July 8 - Heat Biologics, Inc. expects to price its initial public offering of common stock on July 23 for trading on July 24, according to an informed source.

As previously reported, the company plans to price the offering at $10.00 to $12.00 per share.

Heat Biologics will sell 1.65 million shares and there will be a 15% greenshoe for an additional 247,500 shares.

Aegis Capital Corp. is the bookrunner and Cantor Fitzgerald & Co. will be the co-manager.

Proceeds will be used for clinical development of HS-110 and HS-410 and for other general corporate purposes.

The biopharmaceutical company is based in Chapel Hill, N.C. It expects its shares to trade on the Nasdaq under the symbol "HTBX."

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.